Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Chonnam Medical Journal|January 17, 2012
The role of visfatin in diabetic nephropathyYoung Sun Kang, Dae Ryong Cha
Current Diabetes Reports|December 4, 2009
Aldosterone and diabetic kidney diseaseYoung Sun Kang, Dae Ryong Cha
Expert Opinion on Investigational Drugs|April 7, 2011
Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developmentsYoung Sun Kang, Jin Joo Cha, Young Youl Hyun, et al.
Kidney Research and Clinical Practice|February 18, 2016
A case of primary aldosteronism combined with acquired nephrogenic diabetes insipidusKitae Kim, Jae Hyoung Lee, Sun Chul Kim, et al.
Kidney Research and Clinical Practice|March 12, 2021
Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathySang Youb Han, Kyung Hwan Jeong, Chun-Gyoo Ihm, et al.
Diabetes Research and Clinical Practice|April 23, 2010
Plasma concentration of visfatin is a new surrogate marker of systemic inflammation in type 2 diabetic patientsYoung Sun Kang, Hye Kyoung Song, Mi Hwa Lee, et al.
Inflammation|November 19, 2009
Prolonged administration enhances the renoprotective effect of pentoxifylline via anti-inflammatory activity in streptozotocin-induced diabetic nephropathyKum Hyun Han, Sang Youb Han, Han Seong Kim, et al.
Kidney & Blood Pressure Research|January 7, 2024
Dapagliflozin Does Not Protect against Adriamycin-Induced Kidney Injury in MiceJin Joo Cha, Hye-Jin Park, Ji Ae Yoo, et al.
Animal Cells and Systems|April 24, 2023
Puromycin-induced kidney injury and subsequent regeneration in adult zebrafishSoonil Koun, Hye-Jin Park, Su-Min Jung, et al.
Nephrology (Carlton, Vic.)|September 6, 2008
Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patientsGang Jee Ko, Young Sun Kang, Mi Hwa Lee, et al.
Pageof 16